Therapeutic HPV vaccine reduces pre-cancerous cervical dysplasia
A phase 2 study showed that the investigational therapeutic HPV vaccine Vvax001 is effective in treating cervical intraepithelial neoplasia grade 3 (CIN3). Results indicated significant tumor size reduction, with some patients experiencing complete regression. The vaccine demonstrated a strong safety… Read More »Therapeutic HPV vaccine reduces pre-cancerous cervical dysplasia

